Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Age-related Macular Degeneration market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Age-related Macular Degenerationmarket, defines the market attractiveness level of Age-related Macular Degeneration market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Age-related Macular Degeneration industry, describes the types of Age-related Macular Degeneration market, the applications of major players and the market size, and deeply analyzes the current situation of the global Age-related Macular Degeneration market and the development prospects and opportunities of Age-related Macular Degeneration industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Age-related Macular Degeneration market in Chapter 13.
By Player:
Alcon
Avalanche
F Hoffmann-La Roche
Iconic Therapeutics
Bayer HealthCare
Ohr Pharmaceutical
Allergan
Gilead Sciences
Regeneron Pharmaceuticals
Bausch+Lomb
Neurotech Pharmaceuticals
Novartis
By Type:
Wet AMD
Dry AMD
By End-User:
Drugstore
Hospital
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Age-related Macular Degeneration Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Age-related Macular Degeneration Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Age-related Macular Degeneration Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Age-related Macular Degeneration Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Age-related Macular Degeneration Market Analysis and Outlook to 2022
-
7.1 Global Age-related Macular Degeneration Consumption (2017-2022)
-
7.2 United States Age-related Macular Degeneration Consumption (2017-2022)
-
7.3 Europe Age-related Macular Degeneration Consumption (2017-2022)
-
7.4 China Age-related Macular Degeneration Consumption (2017-2022)
-
7.5 Japan Age-related Macular Degeneration Consumption (2017-2022)
-
7.6 India Age-related Macular Degeneration Consumption (2017-2022)
-
7.7 South Korea Age-related Macular Degeneration Consumption (2017-2022)
8 Region and Country-wise Age-related Macular Degeneration Market Analysis and Outlook to 2028
-
8.1 Global Age-related Macular Degeneration Consumption Forecast (2022-2028)
-
8.2 United States Age-related Macular Degeneration Consumption Forecast (2022-2028)
-
8.3 Europe Age-related Macular Degeneration Consumption Forecast (2022-2028)
-
8.4 China Age-related Macular Degeneration Consumption Forecast (2022-2028)
-
8.5 Japan Age-related Macular Degeneration Consumption Forecast (2022-2028)
-
8.6 India Age-related Macular Degeneration Consumption Forecast (2022-2028)
-
8.7 South Korea Age-related Macular Degeneration Consumption Forecast (2022-2028)
9 Global Age-related Macular Degeneration Market Outlook by Types and Applications to 2022
-
9.1 Global Age-related Macular Degeneration Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Wet AMD Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Dry AMD Consumption and Growth Rate (2017-2022)
-
9.2 Global Age-related Macular Degeneration Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Drugstore Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Age-related Macular Degeneration Market Outlook by Types and Applications to 2028
-
10.1 Global Age-related Macular Degeneration Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Wet AMD Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Dry AMD Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Age-related Macular Degeneration Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Drugstore Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Age-related Macular Degeneration Import and Export Analysis (Top 5 Countries)
-
11.1 Global Age-related Macular Degeneration Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Age-related Macular Degeneration Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Age-related Macular Degeneration Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Age-related Macular Degeneration Market Competitive Analysis
-
14.1 Alcon
-
14.1.1 Alcon Company Details
-
14.1.2 Alcon Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Alcon Age-related Macular Degeneration Product and Service
-
14.2 Avalanche
-
14.2.1 Avalanche Company Details
-
14.2.2 Avalanche Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Avalanche Age-related Macular Degeneration Product and Service
-
14.3 F Hoffmann-La Roche
-
14.3.1 F Hoffmann-La Roche Company Details
-
14.3.2 F Hoffmann-La Roche Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 F Hoffmann-La Roche Age-related Macular Degeneration Product and Service
-
14.4 Iconic Therapeutics
-
14.4.1 Iconic Therapeutics Company Details
-
14.4.2 Iconic Therapeutics Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Iconic Therapeutics Age-related Macular Degeneration Product and Service
-
14.5 Bayer HealthCare
-
14.5.1 Bayer HealthCare Company Details
-
14.5.2 Bayer HealthCare Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bayer HealthCare Age-related Macular Degeneration Product and Service
-
14.6 Ohr Pharmaceutical
-
14.6.1 Ohr Pharmaceutical Company Details
-
14.6.2 Ohr Pharmaceutical Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Ohr Pharmaceutical Age-related Macular Degeneration Product and Service
-
14.7 Allergan
-
14.7.1 Allergan Company Details
-
14.7.2 Allergan Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Allergan Age-related Macular Degeneration Product and Service
-
14.8 Gilead Sciences
-
14.8.1 Gilead Sciences Company Details
-
14.8.2 Gilead Sciences Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Gilead Sciences Age-related Macular Degeneration Product and Service
-
14.9 Regeneron Pharmaceuticals
-
14.9.1 Regeneron Pharmaceuticals Company Details
-
14.9.2 Regeneron Pharmaceuticals Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Product and Service
-
14.10 Bausch+Lomb
-
14.10.1 Bausch+Lomb Company Details
-
14.10.2 Bausch+Lomb Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Bausch+Lomb Age-related Macular Degeneration Product and Service
-
14.11 Neurotech Pharmaceuticals
-
14.11.1 Neurotech Pharmaceuticals Company Details
-
14.11.2 Neurotech Pharmaceuticals Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Neurotech Pharmaceuticals Age-related Macular Degeneration Product and Service
-
14.12 Novartis
-
14.12.1 Novartis Company Details
-
14.12.2 Novartis Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Novartis Age-related Macular Degeneration Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Age-related Macular Degeneration
-
Figure Age-related Macular Degeneration Picture
-
Table Global Age-related Macular Degeneration Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Age-related Macular Degeneration Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Age-related Macular Degeneration Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Age-related Macular Degeneration Consumption by Country (2017-2022)
-
Figure United States Age-related Macular Degeneration Consumption and Growth Rate (2017-2022)
-
Table Europe Age-related Macular Degeneration Consumption and Growth Rate (2017-2022)
-
Figure China Age-related Macular Degeneration Consumption and Growth Rate (2017-2022)
-
Figure Japan Age-related Macular Degeneration Consumption and Growth Rate (2017-2022)
-
Figure India Age-related Macular Degeneration Consumption and Growth Rate (2017-2022)
-
Figure South Korea Age-related Macular Degeneration Consumption and Growth Rate (2017-2022)
-
Figure Global Age-related Macular Degeneration Consumption Forecast by Country (2022-2028)
-
Figure United States Age-related Macular Degeneration Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Age-related Macular Degeneration Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Age-related Macular Degeneration Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Age-related Macular Degeneration Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Age-related Macular Degeneration Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Age-related Macular Degeneration Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Wet AMD Consumption and Growth Rate (2017-2022)
-
Figure Global Dry AMD Consumption and Growth Rate (2017-2022)
-
Figure Global Drugstore Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Wet AMD Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dry AMD Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugstore Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Age-related Macular Degeneration Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Age-related Macular Degeneration Export by Region (Top 5 Countries) (2017-2028)
-
Table Alcon (Foundation Year, Company Profile and etc.)
-
Table Alcon Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alcon Age-related Macular Degeneration Product and Service
-
Table Avalanche (Foundation Year, Company Profile and etc.)
-
Table Avalanche Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
Table Avalanche Age-related Macular Degeneration Product and Service
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Age-related Macular Degeneration Product and Service
-
Table Iconic Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Iconic Therapeutics Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
Table Iconic Therapeutics Age-related Macular Degeneration Product and Service
-
Table Bayer HealthCare (Foundation Year, Company Profile and etc.)
-
Table Bayer HealthCare Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer HealthCare Age-related Macular Degeneration Product and Service
-
Table Ohr Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Ohr Pharmaceutical Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ohr Pharmaceutical Age-related Macular Degeneration Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Age-related Macular Degeneration Product and Service
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Age-related Macular Degeneration Product and Service
-
Table Regeneron Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Regeneron Pharmaceuticals Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneron Pharmaceuticals Age-related Macular Degeneration Product and Service
-
Table Bausch+Lomb (Foundation Year, Company Profile and etc.)
-
Table Bausch+Lomb Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bausch+Lomb Age-related Macular Degeneration Product and Service
-
Table Neurotech Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Neurotech Pharmaceuticals Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
Table Neurotech Pharmaceuticals Age-related Macular Degeneration Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Age-related Macular Degeneration Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Age-related Macular Degeneration Product and Service
-
